Application of human iPSC-derived white, beige, and brown adipocytes for metabolic disease modeling and transplantation therapy
Cell Transplantation · 2025-12 · 34
DOI: 10.1177/09636897251346599 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cell Transplantation, online erschienen am 19.06.2025. Verfasst von Yamato Keidai und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diabetes, Endocrinology and Nutrition, Graduate School of Medicine, Kyoto University, Kyoto, Japan. Hauptthemen laut MEDLINE: Induced Pluripotent Stem Cells, Adipocytes, Brown, Metabolic Diseases, Adipocytes, White. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 142 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: JST SPRING, Japan Society of Metabolism and Clinical Nutrition, Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Adipocyte dysfunction plays a critical role in the pathogenesis of metabolic diseases, including type 2 diabetes (T2D). Human induced pluripotent stem cells (hiPSCs) offer a powerful platform for generating white, beige, and brown adipocytes, supporting both disease modeling and therapeutic research. This review provides a comprehensive summary of current differentiation methods to produce three functionally mature adipocyte types from pluripotent stem cells (PSCs), including forced gene expression techniques, developmental biology-inspired approaches, and advanced three-dimensional (3D) culture systems that enhance cellular maturity and functional relevance. PSC-derived white adipocytes contribute to modeling adipocyte dysfunction not only in conditions such as insulin resistance, lipodystrophy, and premature aging but also in more complex metabolic diseases, including T2D, facilitating the investigation of disease mechanisms and the identification of novel therapeutic targets. In addition, iPSC-based models provide a robust platform for exploring genetic regulation by genome-wide association studies (GWAS)–identified variants through population genetics. This review also evaluates the therapeutic potential of iPSC-derived white, beige, and brown adipocytes in cell transplantation therapy for metabolic diseases, with a focus on engraftment potential and metabolic improvement. Enhancing the maturity and subtype specificity of PSC-derived adipocytes is expected to accelerate the development of personalized medicine and innovative therapeutic strategies for metabolic diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Diabetes, Endocrinology and Nutrition, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
- Department of Diabetes and Endocrinology, Medical Research Institute Kitano Hospital, PIIF Tazuke-Kofukai, Osaka, Japan.
- Yutaka Seino Distinguished Center for Diabetes Research, Kansai Electric Power Medical Research Institute, Osaka, Japan.
- Center for One Medicine Innovative Translational Research, Gifu University Institute for Advanced Studies, Gifu, Japan.
ORCID-Profile: Yamato Keidai, Junji Fujikura
Förderung
- JST SPRING
- Japan Society of Metabolism and Clinical Nutrition
- Japan Society for the Promotion of Science
Zitieren
APA
Keidai, Y., Fujikura, J., & Yabe, D. (2025). Application of human iPSC-derived white, beige, and brown adipocytes for metabolic disease modeling and transplantation therapy. Cell Transplantation, 34. https://doi.org/10.1177/09636897251346599
Vancouver
Keidai Y, Fujikura J, Yabe D. Application of human iPSC-derived white, beige, and brown adipocytes for metabolic disease modeling and transplantation therapy. Cell Transplantation. 2025;34. doi:10.1177/09636897251346599
BibTeX
@article{Keidai2025,
author = {Keidai, Yamato and Fujikura, Junji and Yabe, Daisuke},
title = {Application of human iPSC-derived white, beige, and brown adipocytes for metabolic disease modeling and transplantation therapy},
journal = {Cell Transplantation},
year = {2025},
volume = {34},
doi = {10.1177/09636897251346599}
}
EUVIMED